Literature DB >> 6147471

Prophylaxis of Pneumocystis carinii infection in AIDS with pyrimethamine-sulfadoxine.

M S Gottlieb, S Knight, R Mitsuyasu, J Weisman, M Roth, L S Young.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6147471     DOI： 10.1016/s0140-6736(84)90560-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Opportunistic infections in HIV-infected patients.

Authors:  S D Shafran
Journal:  Can J Infect Dis       Date:  1992-03

Review 2.  Pneumocystis carinii, an opportunist in immunocompromised patients.

Authors:  M S Bartlett; J W Smith
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

3.  Fansidar--a treatment for AIDS-related pneumocystis?

Authors:  P M Bath; D A Lillicrap; M Winter
Journal:  Postgrad Med J       Date:  1987-06       Impact factor: 2.401

4.  Pneumonia in the acquired immune deficiency syndrome.

Authors:  N M Johnson
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-04

Review 5.  Pneumocystis carinii pneumonia.

Authors:  J T Macfarlane; R G Finch
Journal:  Thorax       Date:  1985-08       Impact factor: 9.139

Review 6.  Therapy and prophylaxis of systemic protozoan infections.

Authors:  W C Van Voorhis
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

7.  Activity of clindamycin with primaquine against Pneumocystis carinii in vitro and in vivo.

Authors:  S F Queener; M S Bartlett; J D Richardson; M M Durkin; M A Jay; J W Smith
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

8.  Prevention of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus infected patients: a clinical approach comparing aerosolized pentamidine and pyrimethamine/sulfadoxine.

Authors:  S Köppen; T Grünewald; G Jautzke; J Gottschalk; H D Pohle; B Ruf
Journal:  Clin Investig       Date:  1992-06

Review 9.  Pulmonary complications of AIDS: a clinical strategy.

Authors:  J D Edelson; R H Hyland
Journal:  CMAJ       Date:  1989-06-01       Impact factor: 8.262

10.  Pyrimethamine-sulphadoxine: how great the risk?

Authors:  D Stürchler
Journal:  J R Soc Med       Date:  1990-09       Impact factor: 18.000
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.